Search

Search Constraints

You searched for: Author/Creator Kester, Maartje I.

Search Results

1. [P3–226]: PROFILING PERIPHERAL METABOLIC DYSREGULATION IN ALZHEIMER's DISEASE: THE ADDED VALUE OF MULTIPLE SIGNATURES. (1st July 2017)

2. Blood‐based metabolic signatures in Alzheimer's disease. Issue 1 (6th September 2017)

3. Circulating metabolites are associated with brain atrophy and white matter hyperintensities. Issue 2 (4th September 2020)

4. Discriminatory and predictive capabilities of enzyme‐linked immunosorbent assay and multiplex platforms in a longitudinal Alzheimer's disease study. Issue 3 (29th October 2012)

5. LDL cholesterol and uridine levels in blood are potential nutritional biomarkers for clinical progression in Alzheimer's disease: The NUDAD project. Issue 1 (30th December 2020)

6. LDL cholesterol and uridine levels in blood are potential nutritional biomarkers of AD progression: The NUDAD project: Biomarkers (non‐neuroimaging) / Novel biomarkers. (7th December 2020)

7. Nutritional status and structural brain changes in Alzheimer's disease: The NUDAD project. Issue 1 (11th August 2020)

9. O5‐05‐03: Neurogranin, a CSF biomarker for synaptic loss, predicts decline to dementia due to Alzheimer's disease. (1st July 2015)

10. P1‐149: CSF VILIP‐1 AND YKL‐40, NOVEL CANDIDATE BIOMARKERS TO DIAGNOSE, PREDICT, AND MONITOR ALZHEIMER'S DISEASE. (1st July 2014)